Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.42.1 (Delta)NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
AY.42.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.42.1 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.348EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.348NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.348NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.348NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.348NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.428.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.428.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.428.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.428.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-14910.4South Korea
B.1.428.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AJ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AJ.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
AJ.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-3342.44Germany
AJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-1923.32South Korea
AJ.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.459EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.459NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.459NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.459NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.459NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.160.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.29NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.160.29NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.160.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.29NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.415.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.415.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.415.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.415.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.415.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.243.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.243.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.243.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.243.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.243.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.98EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.98NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.98NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.98NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.98NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.566EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.566NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.566NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.566NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.566NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.480EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.480NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used